BCLC Stage C Hepatocellular Carcinoma

18 clinical trials · Condition

Record	Firm	Date
BOLD MRI and FMISO PET for the Assessment of Hypoxic Tumor Microenvironment in Patients with Oligometastatic Liver Cancer Undergoing Yttirum-90 Selective Internal Radiation Therapy (NCT05250895)	Emory University	2022-04-28
Futibatinib and Pembrolizumab for Treatment of Advanced or Metastatic FGF19 Positive BCLC Stage A, B, or C Liver Cancer (NCT04828486)	Mayo Clinic	2021-08-17
Durvalumab and Tremelimumab After Radioembolization for the Treatment of Unresectable, Locally Advanced Liver Cancer (NCT04605731)	City of Hope Medical Center	2021-08-03
Cabozantinib and Pembrolizumab for the First-Line Treatment of Advanced Liver Cancer (NCT04442581)	University of Washington	2021-04-20
HAIC in Combination With PD-1 Inhibitors and Lenvatinib for High Tumor Burden Advanced HCC (CHANCE2416) (NCT06631326)	First Hospital of China Medical University	2021-01-01
The Safety and Efficacy of Thermal Ablation Combined With Apatinib and Carilimub for Advanced Liver Cancer (NCT04204577)	Chinese PLA General Hospital	2019-11-01
Pembrolizumab (MK-3475) in Hepatocellular Carcinoma (NCT02940496)	M.D. Anderson Cancer Center	2016-12-09
Sorafenib Tosylate and Yttrium Y 90 Glass Microspheres in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery (NCT01900002)	M.D. Anderson Cancer Center	2013-09-13

Every clearance here is in the API, with alerts when new ones post.